Otolith Labs announced today that it closed a $20 million Series A financing round by Morningside Ventures. Washington, D.C.-based Otolith plans to use the proceeds to support its ongoing clinical programs, regulatory approvals and commercial launches. The funds build upon previous investments from entrepreneur Mark Cuban and ENT physicians. The company develops a prescription wearable […]